“…MD in subcortical
ROIs is also increasingly used to investigate biomedical (Craiu, 2013; Kregel, et
al., 2015; Simo, et al, 2013),
psychiatric (Buhler and Mann, 2011; Peng, et al, 2012; Rosenbloom, et al, 2003; Serafini, et al, 2014; Wen, et al,
2011), as well as cognitive (Stigler, et
al., 2011) and age-related (Carlesimo, et
al., 2010; Cherubini, et al, 2010;
Fellgiebel, et al, 2006; Fellgiebel and Yakushev, 2011; Holtzer, et al, 2014; Li, et al, 2013b; Muller, et al,
2007; Teipel, et al, 2013)
traits. For example, variation in hippocampus MD has been linked to cognitive
decline (den Heijer, et al, 2012; Piras, et al, 2010), mild cognitive impairment
(MCI), and Alzheimer’s Disease (AD) (Cherubini, et al, 2010; Fellgiebel, et
al., 2006; Kantarci, et al, 2005;
Li, et al, 2013b). …”